Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (10): 1305-1311.doi: 10.12092/j.issn.1009-2501.2025.10.002

Previous Articles     Next Articles

Research progress of hydromorphone in postoperative analgesia for obstetrics and gynecology

JIN Xuedong1, CAO Xin2, GUO Tang2, CHEN Dikun2, WANG Yan1   

  1. 1Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250000, Shandong, China; 2Department of Anesthesiology, Jinan Seventh People's Hospital, Jinan 250100, Shandong, China
  • Received:2025-01-13 Revised:2025-03-17 Online:2025-10-26 Published:2025-10-15

Abstract:

Hydromorphone, a semi-synthetic morphine derivative, offers strong analgesia with fewer side effects than traditional opioids. It has been widely used in multimodal analgesia protocols in obstetrics and gynecology. This paper reviews the current applications and research progress of hydromorphone in postoperative pain management for gynecological patients, assessing its efficacy and safety to provide evidence for clinical practice.

Key words: hydromorphone, gynecological and obstetric surgery, postoperative analgesia, enhanced recovery after surgery

CLC Number: